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Introduction
Stroke or
cerebrovascular accident (CVA) is
the third leading cause of death in
the United States (Mvundura,
McGruder, Khoury, Valdez, &
Yoon, 2011). Ischemic strokes
make up about 86% of the strokes
that occur, (Patel, & White, 2011)
hemorrhagic and cryptogenic
strokes make up for the other 15%.
The topic that is going to be
covered in the poster is ischemic
stroke. There are many risk
factors that can lead to ischemic
strokes and a few different things
that cause ischemic strokes. I
have chosen ischemic strokes as a
topic because I have worked with
this patient population for 8 years
and it has always interested me.
Since this disease affects around
800,000 people a year (Iadecola, &
Anrather, 2011), this makes it an
interesting topic to follow along and
see what can be done to decrease
the risk and new treatment options
that are available.

Signs and
Symptoms
•
•
•
•
•
•

Weakness on one side of the
body
Slurred or incoherent speech
Droop on one side of the face
Visual changes
Loss of sensation
Other neurologic deficits
based on location of stroke
(Kent &Thaler, 2015)

Risk factors
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Hypertension
diabetes mellitus
cigarette smoking
alcohol consumption
coronary artery disease
peripheral vascular disease
atrial fibrillation
carotid stenosis
Dyslipidemia
previous stroke or transient
ischemic attack
family risk
African American or Hispanic
race
Stress
environmental factors
women’s risk factors- hormone
therapy, contraceptives,
pregnancy- associated
disorders (Bushnell &
McCullough, 2014)
(Mvundura, 2011) (Sen, et al,
2013)

Significance of
pathophysiology
•

•

Once the process of blood flow
restriction starts then the
immune and inflammatory
response begins. At this point
the risk factors have nothing to
do with the process.
The most beneficial thing to do
once the stroke happens
would be to suppress the
process of inflammation and
the body’s immune response.
(Bang, Ovbiagele, & Kim,
2015)
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Underlying Pathophysiology
•
•
•
•

•
•
•
•
•

•
•

An ischemic stroke is caused by either a thrombotic event or an embolic event. In a thrombotic event
platelets accumulate in the artery until it is occluded. In an embolic event a clot travels until it occludes a
vessel. (Iadecola & Anrather, 2011)
When a person has an ischemic stroke the blood flow is cut off to a portion of the brain the lack of blood flow
prevents oxygen and glucose to that portion and prevents the brain from producing ATP. ( Iadecola &
Anrather, 2011)
Immunity and inflammation play a large role in the events after the initial insult to the brain. There is a
thought that the brain and the immune system communicate bidirectionally. (Picascia, et al, 2015)
After intracranial arterial occlusion and hypoxia, the event that leads to cell death is the influx of cytoplasmic
calcium (Ca+) that activates calcium dependent hydrolytic enzymes and nitric oxide production. This initiates
the coagulation cascade and activation of complement, platelets, and endothelial cells. (iadecola & Anrather,
2011)
Neutrophils infiltrate the site within 24 hours. ( Iadecola & Anrather, 2011)
Oxidative stress and inflammatory mediators help to breakdown the blood brain barrier. (Picascia, et al,
2015)
In the perivascular space there is activation of macrophages and mast cells causing the release of
vasoactive mediators, proteases along with tumor necrosis factor (TNF) and pro-inflammatory molecules.
(Picascia, et al, 2015)
Danger associated molecular pattern (DAMP) are released. High-mobility group box 1(HMBG1) is one of the
main DAMP molecules involved in ischemic strokes. DAMP’s bind to toll-like receptors (TLRs) which
activates and amplifies the innate response that can exacerbate ischemic damage. (Picascia, et al ,2015)
Since there is a bidirectional interaction between the brain and immune system there is an
immunosuppression that occurs after a stroke. It is marked by a lymphopenia and anti-inflammatory
cytokines. There are also many subtypes of T cells that are present after a stroke. ( Iadecola & Anrather,
2011)
Antibodies against central nervous system antigens develop after an ischemic stroke. This suggests a
humoral immune response to the stroke. This may be related to the long term outcome of the stroke patient.
(Iadecola & Anrather, 2011)
Microglia and macrophages remove the dead cells. Tumor growth factor-beta and interleukin 10 help with
tissue repair and anti-inflammatory properties. Insulin growth factor 1 and vascular endothelial growth factor
help to establish a favorable environment for re-growth. (Iadecola & Anrather, 2011)

.

•
•
•
•
•

•

Monitor neurologic status closely
Monitor cardiac status
Physical, occupational, and speech
therapy
Prevention of complications, like
venous thromboembolisms, infection,
etc.
Appropriate treatments to prevent
future strokes, like antiplatelet
medications or blood thinning
medications, lipid lowering
medications, blood pressure
medications, management of
diabetes mellitus and lifestyle
modifications.
Appropriate discharge planning;
whether patient should go to a skilled
facility, or having outpatient therapy.
(Bernheisel, Schlaudecker, &Leopold,
2011)

Conclusion
Strokes are a very big issue since they
are the number one cause of disability in
the United States, according to Patel and
White, 2011. The biggest way to alter the
amount of strokes that happen are to
prevent them. More and more risk factors
are being found that contribute to strokes.
Once the inflammatory and immune
response begins once triggered by
hypoxia it cannot be reversed. Slowing
the inflammatory and immune responses
triggered by stroke should be an area of
further research since these processes
can make the ischemic damage worse
and alter the outcome of the patient.
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